Postoperative survival of lung cancer patients: Are there predictors beyond TNM?

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1609-1620

  Friedel, Godehard ^a   Fritz, Peter ^b,c   Goletz, Sven ^c   Kristen, Ralf ^c   Brinkmann, Friedhelm ^e   Dierkesmann, Rainer ^a   Schwab, Matthias ^f   Ott, German ^c   Dippon, Jürgen ^d   Alscher, Mark Dominik ^c  

^a Klinik Schillerhohe   (Germany)

^b Institute of Digital Medicine   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

^d UNIVERSITY OF STUTTGART   (Germany)

^e Oncological Cancer Center ^*  (Germany)

^f DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Comorbidity; Lung cancer; Lung function; Random forest method; Survival

Indexed keywords

CREATININE;

ADENOCARCINOMA; ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC BRONCHITIS; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOM FOREST; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; SURVIVAL PREDICTION; UNDERWEIGHT; VITAL CAPACITY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CARDIOVASCULAR DISEASES; COMORBIDITY; CREATININE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXYGEN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 84876759727     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brundage MD, Davies D and Mackillop WJ: Prognostic factors in non-small cell lung cancer. A decade progress. Chest 122: 1037-1057, 2002.
2. Travis WD, Brambilla E, Müller-Hermelink HKand Harris CC: Pathology & Genetics. Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004.
3. Berrino F, DeAngelis R, Sant M, Rosso S, Bielska-Lasota M, Santaguilani M and Eurocare Working group: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: Results of the Eurocare-study. Lancet Oncol 8: 773-783, 2007. (Pubitemid 47321600)
4. TNM Klassifikation maligner Tumoren. 7. Auflage. Herausgeber: Wittekind C, Meyer H (eds). Wiley Blackwell, 2010.
5. TNM Klassifikation maligner Tumoren. 6. Auflage. Wittekind C, Meyer HW (eds). Springer Verlag, 2003.
6. Gawryhoowski J, Gabriel A and Lackowska B: Heterogeneity of stage IIIA non-small lung cancers (NSCLC) and evaluation of late results of surgical treatment. EJSO 29: 178-184, 2003. (Pubitemid 36367351)
7. Birim O, Zuydendorp HM, Kappetein AP, Eijkemans MJ and Bogers AJ: Lung resection for non-small-cell lung cancer in patients older than 70: Mortality, morbidity, and late survival compared with the geneneral population. Ann Thorac Surg 76: 1796-1801, 2003. (Pubitemid 37510479)
8. Birim O, Kappetein AP, van Klaveren RJ and Bogers AJ: Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 32: 12-23, 2003.
9. Birim O, Kappetein AP, Waleboer M, Puvimanasinghe JP, Eijkkemans MJ, Steyerberg EW, Versteegh MI and Bogers AJ: Long-term survival after non-small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg 132: 491-498, 2006. (Pubitemid 44278874)
10. Van der Pijl LL: Birim O, van Gameren M, Kappetein AP, Maat AP, Steyerberg EW and Bogers AJ: Validation of a prognostic model to predict survival after non-small-cell lung cancer surgery. Eur J Cardiothorac Surg 36: 615-619, 2010.
11. Criee CP, Berdel D, Heise D, Kardos P, Köhler D, Leupold W, Magnussen H, Marek W, Merget R, Mitfessel H, Rolke M, Sorichter S, Worth W and Wuthe H: Empfehlungen der Deutschen Atemwegsliga zur Spirometrie. Pneumologie 60: 576-584, 2006. (Pubitemid 44621292)
12. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, URL http://www.R-project.org.
13. Collett D: Modelling Survival Data in Medical Research, 2nd ed. Chapmann & Hall, 2003.
14. Ishwaran H, Kogalur UB, Blackstone EH and Lauer MS: Random survival forests. Ann Appl Statist 2: 841-860, 2008.
15. Ishwaran H and Kogalur UB: Random Survival Forests, R package version 3.6.3., 2012.
16. Fraire AE, Johnson EG, Yesner R, Zhang XB, Spjut HJ and Breenberg SD: Prognostic significance of histological subtype and staging in small cell lung cancers. Hum Pathol 23: 520-528, 1992.
17. Scherbaum WA and Kiess W: Epidemologie und Verlauf Diabetes mellitus in Deutschland. Evidenzbasierte Leitline DDG-Aktualisierung 05/2004. www.deutsche-diabetes-gesellschaft.de/.../EBL-Epidemiologie-Update-2004.pdf.
18. Charloux A, Quoix E, Wolkove N, Small D, Pauli G and Kreisman H: The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 26: 14-23, 1997. (Pubitemid 27129564)
19. Nordquist LT, Simon GR, Cantor A, Alberts WM and Bepler G:. Improved survival in never-smokers vs. current smokers in primary adenocarcinoma of the lung. Chest 126: 347-351, 1997.
20. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA and Morgan CL: Mortality after incident cancer in people with and without type 2 diabetes: Impact of metformin on survival. Diabetes Care 35: 299-304, 2012.
21. Travis, WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely YG, Van SchilI, PE, Garg K, Austin JHM, Asamara H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, IshikawaY, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunissen E, Tsao and Yankelwitz D: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6: 244-285, 2011.
22. Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE and Burdach S: Matrix Metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11: 1086-1092, 2005. (Pubitemid 40175757)
23. Heist RS, Marshall AL, Liu G, Zhou W, Su L, Neuberg D, Lynch TJ, Wain and Christiani DC: Matrix metalloproteinases polymorphisms and survival in stage I non-small cell lung cancer. Clin Cancer Res 12: 5488-5453, 2006.
24. Dippon J, Fritz P, and Kohler M: A statistical approach to case based reasoning with application to breast cancer. Comput Stat Data Anal 40: 570-602, 2002.
25. Bülzebruck H, Krysa S, Bauer E, Probst G, Drings P and Vogt-Moykopf I: Validation of the TNM classification (4th ed) for lung cancer. First results of 1086 patients with surgical treatment. Eur J Cardiothorac Surg 5: 356-362, 1991.
26. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L: The IASLC Lung Cancer Staging Project:proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706-714, 2007. (Pubitemid 47357522)
27. Goldstraw P: Staging Manual in Thoracic Oncology. International Association for the Study of Lung Cancer. Editorial Rx Press, Orange Park FL, 2009.
28. Maeda R, Yoshida J, Genichirio I, Hshida T, Aokage KA, Nishimura M, Nshiwaki Y and Nagai K: Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest 138: 357-362, 2010.